Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
AB-16B5 + Docetaxel for Non-Small Cell Lung Cancer
Recruiting3 awardsPhase 2
Houston, Texas
This trial will study a new cancer treatment for people who have failed other treatments. The new treatment is a combination of two drugs given weekly and every three weeks, respectively.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.